Artelo Biosciences Ownership 2024 | Who Owns Artelo Biosciences Now?
Institutional Ownership
3.26%
Insider Ownership
0.83%
Retail Ownership
95.91%
Institutional Holders
11.00
Artelo Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA ADVISERS, LP | 11.94% | 0.00% | 27,262 | -8,700 | -24.19% | 63,248,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.00% | - | 13,707 | - | - | 31,800,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.81% | 0.00% | 4,126 | 2,493 | 152.66% | 10,000 | Mar 31, 2023 |
| UBS GROUP AG | 1.04% | - | 2,378 | -673 | -22.06% | 5,517,000 | Mar 31, 2023 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 0.03% | - | 72 | - | - | 167,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.01% | - | 20 | -5 | -20.00% | 46,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 18 | - | - | 42,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -62,576 | -100.00% | - | Mar 31, 2023 |
Artelo Biosciences's largest institutional shareholder is TWO SIGMA ADVISERS, LP, holding 11.94% of the company's total share outstanding, currently valued at $63.25M. The top 10 institutional shareholders own together 20.83% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.81% | 0.00% | 4,126 | 2,493 | 152.66% | 10,000 | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | 11.94% | 0.00% | 27,262 | -8,700 | -24.19% | 63,248,000 | Mar 31, 2023 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 0.03% | - | 72 | - | - | 167,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.00% | - | 13,707 | - | - | 31,800,000 | Mar 31, 2023 |
| UBS GROUP AG | 1.04% | - | 2,378 | -673 | -22.06% | 5,517,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 18 | - | - | 42,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.01% | - | 20 | -5 | -20.00% | 46,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -62,576 | -100.00% | - | Mar 31, 2023 |
The largest Artelo Biosciences shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 4.13K shares of Artelo Biosciences (ARTL), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.81% | 0.00% | 4,126 | 2,493 | 152.66% | 10,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 18 | - | - | 42,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.00% | - | 13,707 | - | - | 31,800,000 | Mar 31, 2023 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 0.03% | - | 72 | - | - | 167,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.01% | - | 20 | -5 | -20.00% | 46,000 | Mar 31, 2023 |
| UBS GROUP AG | 1.04% | - | 2,378 | -673 | -22.06% | 5,517,000 | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | 11.94% | 0.00% | 27,262 | -8,700 | -24.19% | 63,248,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -62,576 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Artelo Biosciences's largest institutional buyer is TOWER RESEARCH CAPITAL LLC (TRC). The company purchased 2.49K stocks of ARTL, valued at $10.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | - | - | - | -62,576 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | 11.94% | 0.00% | 27,262 | -8,700 | -24.19% | 63,248,000 | Mar 31, 2023 |
| UBS GROUP AG | 1.04% | - | 2,378 | -673 | -22.06% | 5,517,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.01% | - | 20 | -5 | -20.00% | 46,000 | Mar 31, 2023 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 0.03% | - | 72 | - | - | 167,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.00% | - | 13,707 | - | - | 31,800,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 18 | - | - | 42,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.81% | 0.00% | 4,126 | 2,493 | 152.66% | 10,000 | Mar 31, 2023 |
As of Mar 31 2023, Artelo Biosciences's biggest institutional seller is VANGUARD GROUP INC. The company sold -62.58K shares of ARTL, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | - | - | - | -62,576 | -100.00% | - | Mar 31, 2023 |
Artelo Biosciences's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -62.58K shares, valued at -, as of undefined.
Artelo Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD INDEX FUNDS | 0.00% | 678,172 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 162,750 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 19,516 | -64 | -0.33% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 3,938 | - | - | Mar 31, 2024 |
Artelo Biosciences's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 678.17K shares, compromising 0.00% of its total assets.
Artelo Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 22 | 11 | -26.67% |
| 31 Mar, 22 | 15 | -6.25% |
| 31 Dec, 21 | 16 | 14.29% |
| 30 Sep, 21 | 14 | -12.50% |
| 30 Jun, 21 | 16 | 33.33% |
| 31 Mar, 21 | 12 | 200.00% |
| 31 Dec, 20 | 4 | - |
| 30 Jun, 20 | 2 | - |
| 31 Mar, 20 | 2 | 100.00% |
| 31 Dec, 19 | 1 | -66.67% |
| 30 Sep, 19 | 3 | - |
As of 30 Jun 22, 11 institutions are holding Artelo Biosciences's shares, representing a decrease of -26.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 22 | 1,383,628 | -5.65% |
| 31 Mar, 22 | 1,466,422 | -21.68% |
| 31 Dec, 21 | 1,872,284 | -5.76% |
| 30 Sep, 21 | 1,986,685 | -28.32% |
| 30 Jun, 21 | 2,771,440 | 108.39% |
| 31 Mar, 21 | 1,329,928 | 296.68% |
| 31 Dec, 20 | 335,268 | - |
| 30 Jun, 20 | 14,923 | -0.66% |
| 31 Mar, 20 | 15,022 | 5.62% |
| 31 Dec, 19 | 14,223 | -27.09% |
| 30 Sep, 19 | 19,507 | - |
Artelo Biosciences (ARTL) has 1.38M shares outstanding as of 30 Jun 22, down -5.65% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 22 | 3.26% | 27.12% |
| 31 Mar, 22 | 3.47% | 9.16% |
| 31 Dec, 21 | 6.15% | 5.44% |
| 30 Sep, 21 | 10.64% | 7.40% |
| 30 Jun, 21 | 11.99% | 19.56% |
| 31 Mar, 21 | 7.83% | 72.73% |
| 31 Dec, 20 | 3.28% | - |
| 30 Jun, 20 | 0.15% | 675.78% |
| 31 Mar, 20 | 0.15% | 758.76% |
| 31 Dec, 19 | 0.14% | 381.93% |
| 30 Sep, 19 | 0.19% | - |
As of 30 Jun 22, Artelo Biosciences is held by 3.26% institutional shareholders, representing a 27.12% growth compared to 31 Mar 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 22 | 5 | -44.44% |
| 31 Mar, 22 | 9 | 12.50% |
| 31 Dec, 21 | 8 | 14.29% |
| 30 Sep, 21 | 7 | -22.22% |
| 30 Jun, 21 | 9 | -10.00% |
| 31 Mar, 21 | 10 | 150.00% |
| 31 Dec, 20 | 4 | - |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | - | -100.00% |
| 30 Sep, 19 | 3 | - |
5 institutional shareholders have increased their position in ARTL stock as of 30 Jun 22 compared to 9 in the previous quarter (a -44.44% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 22 | 2 | -50.00% |
| 31 Mar, 22 | 4 | - |
| 31 Dec, 21 | 4 | -20.00% |
| 30 Sep, 21 | 5 | 25.00% |
| 30 Jun, 21 | 4 | 300.00% |
| 31 Mar, 21 | 1 | - |
| 31 Dec, 20 | - | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | -100.00% |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | - | - |
2 institutional shareholders have reduced their position in ARTL stock as of 30 Jun 22 compared to 4 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 22 | 11 | -26.67% | 1,383,628 | -5.65% | 3.26% | 27.12% | 5 | -44.44% | 2 | -50.00% |
| 31 Mar, 22 | 15 | -6.25% | 1,466,422 | -21.68% | 3.47% | 9.16% | 9 | 12.50% | 4 | - |
| 31 Dec, 21 | 16 | 14.29% | 1,872,284 | -5.76% | 6.15% | 5.44% | 8 | 14.29% | 4 | -20.00% |
| 30 Sep, 21 | 14 | -12.50% | 1,986,685 | -28.32% | 10.64% | 7.40% | 7 | -22.22% | 5 | 25.00% |
| 30 Jun, 21 | 16 | 33.33% | 2,771,440 | 108.39% | 11.99% | 19.56% | 9 | -10.00% | 4 | 300.00% |
| 31 Mar, 21 | 12 | 200.00% | 1,329,928 | 296.68% | 7.83% | 72.73% | 10 | 150.00% | 1 | - |
| 31 Dec, 20 | 4 | - | 335,268 | - | 3.28% | - | 4 | - | - | - |
| 30 Jun, 20 | 2 | - | 14,923 | -0.66% | 0.15% | 675.78% | 1 | - | - | - |
| 31 Mar, 20 | 2 | 100.00% | 15,022 | 5.62% | 0.15% | 758.76% | 1 | - | - | -100.00% |
| 31 Dec, 19 | 1 | -66.67% | 14,223 | -27.09% | 0.14% | 381.93% | - | -100.00% | 1 | - |
| 30 Sep, 19 | 3 | - | 19,507 | - | 0.19% | - | 3 | - | - | - |
Artelo Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Artelo Biosciences's stock was made by FAVORITO TAMARA A on Mar 01 2024, selling 1,083 shares at $2.01 per share (valued at $2.18K).
Artelo Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 29 | 40 | 72.50% |
| Q3 2023 | 6 | - | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 1 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 10 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 7 | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 8 | - | - |
| Q4 2020 | 1 | - | - |
| Q2 2020 | 4 | - | - |
| Q4 2019 | 8 | - | - |
| Q3 2019 | 6 | 1 | 600.00% |
| Q2 2019 | - | 9 | - |
| Q1 2018 | - | 2 | - |
| Q2 2017 | - | 2 | - |
| Q4 2009 | - | 6 | - |
| Q1 2008 | 1 | 2 | 50.00% |
| Q3 2007 | 1 | - | - |
29 total buy trades, and 40 total sell trades (buy/sell ratio of 0.72%) were made by Artelo Biosciences's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | 4 | - | - |
| Q4 2019 | 6 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2018 | - | - | - |
| Q2 2017 | - | - | - |
| Q4 2009 | - | - | - |
| Q1 2008 | - | - | - |
| Q3 2007 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Artelo Biosciences's stocks.
Artelo Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| MGTA | Dianthus Therapeutics, Inc. |
| FRTX | Fresh Tracks Therapeutics, Inc. |
| AXLA | Axcella Health Inc. |
| HSTO | Histogen Inc. |
| KTTA | Pasithea Therapeutics Corp. |
| AKTX | Akari Therapeutics, Plc |
| VCNX | Vaccinex, Inc. |
| MNOV | MediciNova, Inc. |
| CRIS | Curis, Inc. |
| SLRX | Salarius Pharmaceuticals, Inc. |
| ALRN | Aileron Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
ARTL Ownership FAQ
Who Owns Artelo Biosciences?
Artelo Biosciences is owned by institutional shareholders (3.26%), insiders (0.83%), and public (95.91%). The largest institutional shareholder of Artelo Biosciences is TWO SIGMA ADVISERS, LP (11.94% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Artelo Biosciences?
Artelo Biosciences's major institutional shareholders are TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, TOWER RESEARCH CAPITAL LLC (TRC), UBS GROUP AG, and CREATIVE FINANCIAL DESIGNS INC /ADV. The top five shareholders own together 20.82% of the company's share outstanding.
How many Artelo Biosciences shareholders are there?
As of Jun 2022, there are 11 institutional shareholders of Artelo Biosciences.
What percentage of Artelo Biosciences is owned by TWO SIGMA ADVISERS, LP?
TWO SIGMA ADVISERS, LP owns 27.26K shares of Artelo Biosciences, representing 11.94% of the company's total shares outstanding, valued at $63.25M (as of Mar 2023).
What percentage of Artelo Biosciences is owned by GEODE CAPITAL MANAGEMENT, LLC?
As of Mar 2023, GEODE CAPITAL MANAGEMENT, LLC holds 13.71K shares of Artelo Biosciences (ARTL), compromising 6.00% of the company, valued at $31.8M.
What percentage of Artelo Biosciences is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Artelo Biosciences. The company owns 4.13K of the company's shares outstanding (worth $10K).